Statement of Ownership (sc 13g)
February 02 2015 - 3:28PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment No. ________)*
SYNERGY STRIPS
CORP.
(Name
of Issuer)
COMMON STOCK
(Title
of Class of Securities)
87165D 109
(CUSIP
Number)
Jack Ross
3435 Ocean Park
#107-447, Santa Monica, CA 90405
(615) 939-9004
(Name,
Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
JANUARY 22, 2015
(Date
of Event which Requires Filing of this Statement)
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
o |
Rule 13d-1(b) |
x |
Rule 13d-1(c) |
o |
Rule 13d-1(d) |
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect
to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.
The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP
No. 87165D 109 |
13G |
Page
2 of 5 Pages |
|
|
|
|
|
|
|
|
1. |
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Knight Therapeutics (Barbados)
Inc. |
|
|
2. |
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) o
(b) o |
|
|
3. |
|
SEC
USE ONLY |
|
|
4. |
|
CITIZENSHIP
OR PLACE OF ORGANIZATION Barbados |
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
|
|
|
5. |
|
SOLE
VOTING POWER 8,179,9461 |
6. |
|
SHARED
VOTING POWER 0 |
7. |
|
SOLE
DISPOSITIVE POWER 8,179,9461 |
8. |
|
SHARED
DISPOSITIVE POWER 0 |
|
|
|
|
|
9. |
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,179,9461 |
|
|
10. |
|
CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) ¨ |
|
|
11. |
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11.5%1 |
|
|
12. |
|
TYPE
OF REPORTING PERSON (see instructions) CO |
|
|
1 Includes
3,584,759 million shares that may be acquired upon the exercise of warrants
CUSIP
No. 87165D 109 |
13G |
Page 3
of 5 Pages |
Item
1.
|
(a) |
Name
of Issuer
Synergy Strips Corp. |
|
|
|
|
(b) |
Address of Issuer’s
Principal Executive Offices
3435 Ocean Park #107-447, Santa Monica, CA 90405 |
|
|
|
Item
2.
|
(a) |
Name
of Person Filing
Knight Therapeutics (Barbados) Inc. |
|
|
|
|
(b) |
Address of the
Principal Office or, if none, residence
Chancery House, High Street, Bridgetown, Barbados |
|
|
|
|
(c) |
Citizenship
Barbados |
|
|
|
|
(d) |
Title of Class
of Securities
Common Stock, par value $0.00001 per share |
|
|
|
|
(e) |
CUSIP Number
87165D 109 |
Item 3. | If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
Not
Applicable
|
(a) |
o |
Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
|
|
|
|
|
(b) |
o |
Bank as defined
in section 3(a)(6) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
(c) |
o |
Insurance company
as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
(d) |
o |
Investment company
registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
|
|
|
|
|
(e) |
o |
An investment
adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
(f) |
o |
An employee benefit
plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
(g) |
o |
A parent holding
company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
|
|
|
|
|
(h) |
o |
A savings associations
as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
|
|
|
|
(i) |
o |
A church plan
that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3); |
|
|
|
|
|
(j) |
o |
Group, in accordance
with §240.13d-1(b)(1)(ii)(J). |
CUSIP
No. 87165D 109 |
13G |
Page 4
of 5 Pages |
Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in
Item 1.
|
(a) |
Amount
beneficially owned: 8,179,9461 |
|
|
|
|
(b) |
Percent of class: 11.5%1 |
|
|
|
|
(c) |
Number of shares
as to which the person has: |
|
|
|
|
(i) |
Sole power to
vote or to direct the vote 8,179,9461 |
|
|
|
|
(ii) |
Shared power to
vote or to direct the vote 0 |
|
|
|
|
(iii) |
Sole power to
dispose or to direct the disposition of 8,179,9461 |
|
|
|
|
(iv) |
Shared power to
dispose or to direct the disposition of 0 |
|
|
|
Instruction.
For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).
Item 5. | Ownership
of Five Percent or Less of a Class. |
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following o.
Instruction.
Dissolution of a group requires a response to this item.
Item 6. | Ownership
of More than Five Percent on Behalf of Another Person. |
Not
Applicable
Item 7. | Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. |
Not
Applicable
Item 8. | Identification
and Classification of Members of the Group. |
See
Item 4 of this Schedule 13G
Item 9. | Notice
of Dissolution of Group. |
Not
Applicable
1 Includes 3,584,759 million
shares that may be acquired upon the exercise of warrants
CUSIP
No. 87165D 109 |
13G |
Page 5
of 5 Pages |
|
|
|
|
|
(a) |
|
The
following certification shall be included if the statement is filed pursuant to §240.13d-1(b): |
|
|
|
|
|
|
|
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
|
|
|
|
|
|
(b) |
|
The
following certification shall be included if the statement is filed pursuant to §240.13d-1(c): |
|
|
|
|
|
|
|
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
|
|
|
|
|
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
|
|
02/02/2015
|
|
Date |
|
|
|
/s/
Andrew Ferreira
|
|
Signature |
|
|
|
Andrew
Ferreira, Director
|
|
Name/Title |
Synergy CHC (CE) (USOTC:SNYR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Synergy CHC (CE) (USOTC:SNYR)
Historical Stock Chart
From Jul 2023 to Jul 2024